Washington Trust Bank’s Purple Biotech PPBT Stock Holding History

Washington Trust Bank’s Portfolio PPBT Stock Details PPBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-82	Closed	-$33K	–	236
2022 Q3	$33K	Hold	82	–	–	﹤0.01%	211
2022 Q2	$39K	Hold	82	–	–	0.01%	210
2022 Q1	$65K	Hold	82	–	–	0.01%	229
2021 Q4	$64K	Hold	82	–	–	0.01%	232
2021 Q3	$75K	Hold	82	–	–	0.01%	206
2021 Q2	$80K	Hold	82	–	–	0.01%	184
2021 Q1	$68K	Hold	82	–	–	0.01%	185
2020 Q4	$63K	Buy	+82	New	+$69.1K	0.01%	183

Other funds holding PPBT

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GSC

Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return

VVP

Venture Visionary Partners Sylvania, Ohio $3.6B AUM 30.03% 1-Year Est. Return

WAOI

Wealth Advisors of Iowa West Des Moines, Iowa $369M AUM 18.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Fiduciary Alliance Greenville, South Carolina $1.48B AUM 24.99% 1-Year Est. Return

Washington Trust Bank's PPBT Position: Q4 2022 in Review

Washington Trust Bank sold out of Purple Biotech (PPBT) in Q4 2022, closing a stake of 82 shares — an estimated $33K sold.

Washington Trust Bank first reported a position in PPBT in Q4 2020 and held it in 8 quarters. The position peaked at $80K in Q2 2021. 14 funds tracked by Wall St. Rank hold PPBT as of Q4 2022.

Washington Trust Bank reported no remaining Purple Biotech position as of Q4 2022 after selling out during the quarter.
Washington Trust Bank sold 82 Purple Biotech shares in Q4 2022, an estimated $33K.
Washington Trust Bank first reported a position in Purple Biotech in Q4 2020 and held it in 8 quarters.
Washington Trust Bank's Purple Biotech position peaked at $80K in Q2 2021.
14 funds tracked by Wall St. Rank held Purple Biotech as of Q4 2022.

Based on Washington Trust Bank's 13F filing for Q4 2022, filed 6 Feb 2023.